Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
نویسندگان
چکیده
The inhibition of enzyme subgroups tyrosine kinases can block the ability various cytokines at same time. Tyrosine kinase inhibitors are a class drugs that be used either primarily as oral medicines or in dermatological definitions locally. In several skin problems, restraint has been demonstrated to advantageous. Aim this article is explore role diseases. have guaranteed response psoriasis, alopecia areata, Vitiligo, while variable other disorders, including atopic dermatitis, chronic actinic dermatomyositis, erythema multiforme, graft-versus-host disease, hypereosinophillic syndrome, STING vasculopathy, palmoplantar pustulosis and lupus. approach dermatology met with incredible interest. This prescriptions generously propel treatment inflammatory immune mediated dermatoses. It still too early make strong inference regarding these medicines' place treatment, even though evidence provides promising results.
منابع مشابه
A review of three systemic retinoids in dermatology: acitretin, isotretinoin and bexarotene
Retinoids are synthetic and natural analogues of vitamin A that have various effects on cellular differentiation, cellular proliferation, immune system, and embryonic development. The present study reviews the history of systemic retinoids in medicine, the structure of syn
متن کاملMyeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strategy
MPNs including a heterogeneous group of clonal or oligoclonal hamtopathies characterized by proliferation and accumulation of mature myeloid cells. JAK2 tyrosine kinase mutation is the most common molecular lesion identified in 90% of cases. JAK2 is involved in EPO signaling pathway, and mutations in it lead to EPO-independent spontaneous phosphorylation. Most tyrosine kinase inhibitors (TKI) a...
متن کاملPromising role of Bruton’s Tyrosine Kinase Inhibitors in Treatment of COVID-19
Severe acute respiratory syndrome coronavirus-2 has led to a widespread pandemic whose spread is astonishing, its treatment is uncertain, mortality is significant, and associated socioeconomic complications are uncontrollable. Although little is known about the pathogenesis of the disease, severe cases of COVID-19 are usually associated with cytokine release syndrome and high serum levels of in...
متن کاملTyrosine Kinase Inhibitors and Pregnancy
The management of patients with chronic myeloid leukemia (CML) during pregnancy has become recently a matter of continuous debate. The introduction of the Tyrosine Kinase Inhibitors (TKIs) in clinical practice has dramatically changed the prognosis of CML patients; in fact, patients diagnosed in chronic phase can reasonably expect many years of excellent disease control and good quality of life...
متن کاملTyrosine Kinase Inhibitors and Interferon
The use of interferon-a (INF) in chronic myeloid leukemia, when it started in the 80s, was considered as a breakthrough in the therapy of this disease; INF administered alone or in combination with aracytin was the standard choice for treatment for Chronic Myeloid Leukemia (CML) patients unfit for bone marrow transplantation. With the appearance of the first Tyrosine Kinase Inhibitor (TKI) (ima...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of dermatology and dermatitis
سال: 2021
ISSN: ['2578-8949']
DOI: https://doi.org/10.31579/2578-8949/075